Scandinavian Biopharma AB   Report issue

For profit Phase 2
Founded: Solna Sweden (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2015
NCT02531802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Scandinavian Biopharma AB

Active Ingredients

Drugs in Phase 2 Trials (5)

dmlt (1 trial)

e. coli etvax (1 trial)

etec vaccine (1 trial)

etvax (1 trial)

sodium bicarbonate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5